Cargando…
Proteomic and phosphoproteomic analyses of myectomy tissue reveals difference between sarcomeric and genotype-negative hypertrophic cardiomyopathy
Hypertrophic cardiomyopathy (HCM) is a genetically heterogenous condition with about half of cases remaining genetically elusive or non-genetic in origin. HCM patients with a positive genetic test (HCM(Sarc)) present earlier and with more severe disease than those with a negative genetic test (HCM(N...
Autores principales: | Garmany, Ramin, Bos, J. Martijn, Dasari, Surendra, Johnson, Kenneth L., Tester, David J., Giudicessi, John R., dos Remedios, Cristobal, Maleszewski, Joseph J., Ommen, Steve R., Dearani, Joseph A., Ackerman, Michael J. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group UK
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10474105/ https://www.ncbi.nlm.nih.gov/pubmed/37658118 http://dx.doi.org/10.1038/s41598-023-40795-1 |
Ejemplares similares
-
Clinical course of patients with hypertrophic cardiomyopathy away from tertiary referral care
por: Garmany, Ramin, et al.
Publicado: (2023) -
Surgical management of diastolic heart failure after septal myectomy for obstructive hypertrophic cardiomyopathy
por: Sun, Daokun, et al.
Publicado: (2021) -
Association of Preoperative Sleep-Disordered Breathing With Functional Status After Septal Myectomy for Obstructive Hypertrophic Cardiomyopathy
por: Sun, Daokun, et al.
Publicado: (2022) -
Prevalence and potential genetic determinants of young sudden unexplained death victims with suspected arrhythmogenic mitral valve prolapse syndrome
por: Giudicessi, John R., et al.
Publicado: (2021) -
Marked Up-Regulation of ACE2 in Hearts of Patients With Obstructive Hypertrophic Cardiomyopathy: Implications for SARS-CoV-2–Mediated COVID-19
por: Bos, J. Martijn, et al.
Publicado: (2020)